George Mondo

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Daily suppression of herpes simplex virus type 2 (HSV-2) reduces plasma HIV-1 concentrations and modestly delayed HIV-1 disease progression in one clinical trial. We investigated the(More)
  • 1